title: Sp1 trans-activates and is required for maximal aldosterone induction of the αENaC gene in collecting duct cells.
abstract: The epithelial Na+ channel (ENaC) in the distal nephron constitutes the rate-limiting step for renal sodium reabsorption. Aldosterone increases tubular sodium absorption in large part by increasing αENaC transcription in collecting duct principal cells. We previously reported that Af9 binds to +78/+92 of αENaC and recruits Dot1a to repress basal and aldosterone-sensitive αENaC transcription in mouse inner medullary collecting duct (mIMCD)3 cells. Despite this epigenetic repression, basal αENaC transcription is still evident and physiologically necessary, indicating basal operation of positive regulators. In the present study, we identified Sp1 as one such regulator. Gel shift and antibody competition assays using a +208/+240 probe revealed DNA-Sp1-containing complexes in mIMCD3 cells. Mutation of the +222/+229 element abrogated Sp1 binding in vitro and in promoter-reporter constructs stably expressed in mIMCD3 cells. Compared with the wild-type promoter, an αENaC promoter-luciferase construct with +222/+229 mutations exhibited much lower activity and impaired trans-activation in Sp1 overexpression experiments. Conversely, Sp1 knockdown inhibited endogenous αENaC mRNA and the activity of the wild-type αENaC promoter but not the mutated construct. Aldosterone triggered Sp1 recruitment to the αENaC promoter, which was required for maximal induction of αENaC promoter activity and was blocked by spironolactone. Sequential chromatin immunoprecipitation assays and functional tests of +78/+92 and +222/+229 αENaC promoter mutants indicated that while Sp1, Dot1a, and Af9 co-occupy the αENaC promoter, the Sp1 effects are functionally independent from Dot1a and Af9. In summary, Sp1 binding to a cis-element at +222/+229 represents the first identified constitutive driver of αENaC transcription, and it contributes to maximal aldosterone trans-activation of αENaC.
authors.affiliation: Div. of Renal Diseases and Hypertension, The Univ. of Texas Medical School at Houston, 6431 Fannin, MSB 5.124, Houston, TX 77030, USA.
authors.forename: Zhiyuan
authors.initials: Z
authors.lastname: Yu
authors.forename: Qun
authors.initials: Q
authors.lastname: Kong
authors.forename: Bruce C
authors.initials: BC
authors.lastname: Kone
mesh_terms: D000450:Aldosterone / Q000494:pharmacology*; D000818:Animals; D002478:Cells, Cultured; D044127:Epigenesis, Genetic / Q000502:physiology; D053503:Epithelial Sodium Channels / Q000187:drug effects / Q000235:genetics* / Q000378:metabolism; D007685:Kidney Tubules, Collecting / Q000166:cytology; D051379:Mice; D011401:Promoter Regions, Genetic / Q000187:drug effects; D016329:Sp1 Transcription Factor / Q000378:metabolism / Q000502:physiology*; D015534:Trans-Activators / Q000494:pharmacology; D014158:Transcription, Genetic / Q000187:drug effects
chemical_list: D053503:Epithelial Sodium Channels; C507047:Scnn1a protein, mouse; D016329:Sp1 Transcription Factor; D015534:Trans-Activators; D000450:Aldosterone
keywords: chromatin; epigenetic; gene expression; transcription factor